German Cancer Research Center

German Cancer Research Center

German Cancer Research Center

Overview
Date Founded

1964

Headquarters

Im Neuenheimer Feld 280,Heidelberg, Baden Wuerttemberg 69120

Type of Company

Private

Employees (Worldwide)

5,001 - 10K

Industries

Hospitals & Patient Services
Biotechnology

Company Description

German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany.

Executives & Employees

Head of Division

Director-Administration & Commercial

Board of Directors

Industrial Advisor at EQT Partners AB

Paths to German Cancer Research Center
Potential Connections via
Relationship Science
You
German Cancer Research Center
Advisors & Consultants
Legal Advisor

Partner at Dechert LLP

Clients

Heidelberg Pharma AG is a biopharmaceutical company, which engages in the research and development of drugs for cancer patients. The firm focuses on oncology; and development Amanitin, a toxin used in cancer therapies. It also offers tumor implantation models, inflammatory and autoimmune diseases, and bioanalytics services. The company was founded by Olaf G. Wilhelm, Manfred Schmitt, Viktor Magdolen, Heinrich Graeff, Bernd Gänsbacher, Horst Kessler, Peter Nawroth, and Thomas Luther in September 1997 and is headquartered in Ladenburg, Germany.

Investments
Details Hidden

Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by German Cancer Research Center. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of German Cancer Research Center's profile does not indicate a business or promotional relationship of any kind between RelSci and German Cancer Research Center.